Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
24 November, 2017 20:38 IST
Dr. Reddy's Lab enters into global licensing pact with CHD Bioscience
Source: IRIS | 28 Jul, 2017, 10.13AM
Comments  |  Post Comment

Dr Reddy's Laboratories and CHD Bioscience Inc., a privately-held biopharmaceutical company, announced a global licensing agreement for the clinical development and commercialization of Dr. Reddy's phase III clinical trial candidate, DFA-02. It is intended to be used for the prevention of surgical site infections, following non-emergency, elective colorectal surgery. Phase II studies for DFA-02 have been successfully completed, and the product will be transitioning to pivotal Phase III registration studies.

Under the terms of the agreement, Dr. Reddy's (Q,N,C,F)* would receive equity in CHD valued at USD 30 million upon an IPO of CHD or a minimum of USD 30 million in cash within 18 months of execution of the agreement.

Dr. Reddy's will also receive additional milestone payments of USD 40 million upon USFDA approval. In addition, CHD will pay Dr. Reddy's double-digit royalties on sales and commercial milestones.

Shares of the company declined Rs 137.5, or 5.25%, to trade at Rs 2,483.95. The total volume of shares traded was 52,106 at the BSE (10.02 a.m., Friday).



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Indian Hume Pipe secures order worth Rs 1.19 bn - 24-Nov-2017 15:14
Arshiya signs definitive agreements with Ascendas - 24-Nov-2017 11:20
IMP Powers commissions 20 KW hydro-kinetic project - 24-Nov-2017 10:38
Reliance concludes sale of certain assets operated by Carrizo Oil & Gas - 24-Nov-2017 10:25
Zydus Cadila gets USFDA nod for Minocycline HCl ER tablets - 24-Nov-2017 10:22
Zydus Cadila gets tentative approval for Tadalafil tablets - 24-Nov-2017 10:19
CG Power bags order worth Rs 1.11 bn from Indian Railways - 24-Nov-2017 10:09
Welspun Corp bags order for supply of 392K MTs pipes - 24-Nov-2017 10:04
Thomas Cook to sell 5.42% stake in Quess Corp via OFS - 23-Nov-2017 10:28
Tata Tele subscribers commence transitioning to Airtel network - 23-Nov-2017 10:13
Glenmark Pharma gets nod for generic Loestrin Fe 1/20 tablets - 22-Nov-2017 11:27
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer